Literature DB >> 33454778

Changing the paradigm for post-MI cholesterol lowering from intensive statin monotherapy towards intensive lipid-lowering regimens and individualized care.

Kausik K Ray1.   

Abstract

Entities:  

Year:  2021        PMID： 33454778     DOI： 10.1093/eurheartj/ehaa1008

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  2 in total

Review 1.  [Lipid lowering: new agents and new concepts].

Authors:  Julia Brandts; Marlo Verket; Dirk Müller-Wieland
Journal:  Herz       Date:  2022-08-26       Impact factor: 1.740

Review 2.  The Role of RNA-Targeted Therapeutics to Reduce ASCVD Risk: What Have We Learned Recently?

Authors:  Marcio H Miname; Viviane Z Rocha; Raul D Santos
Journal:  Curr Atheroscler Rep       Date:  2021-06-19       Impact factor: 5.113
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.